InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OFW | Ann: Completion of Capital Raising and Corporate Action | 07/02/17 | 2 | 951 | |||
|
|||||||
OFW | Ann: ASX Notice - Reinstatement of Official Quotation | 28/12/16 | 0 | 357 | |||
|
|||||||
OFW | Ann: Reinstatement to Official Quotation 30 December 2016 | 23/12/16 | 0 | 330 | |||
|
|||||||
OFW | Ann: ASX Notice - Reinstatement to Official Quotation | 23/12/16 | 0 | 309 | |||
|
|||||||
OFW | Ann: Pre-reinstatement Disclosure | 23/12/16 | 0 | 179 | |||
|
|||||||
OFW | Ann: Initial Director Interest Notices | 23/12/16 | 0 | 171 | |||
|
|||||||
OFW | Ann: Final Director Interest Notices | 23/12/16 | 0 | 95 | |||
|
|||||||
OFW | Ann: Appendix 3B | 23/12/16 | 0 | 211 | |||
|
See All Discussions